Clinical Maestro 2.4 Brings New Speed and Agility to Clinical Trial Budgeting and Outsourcing
Strategikon Introduces New Generation, State of the Art Clinical Costing Tool for Service Providers and Sponsors SAN FRANCISCO, September 28, 2021 -- Strategikon Pharma announced a major update to their [...]
Strategikon Enhances Clinical Trial Planning and Outsourcing. Speeds Time-to-Market.
Clinical Maestro® Capabilities Boost Clinical Trial Business Operations Performance for Biopharma Sponsors SAN FRANCISCO, August 3, 2021 — Strategikon Pharma announced a global update to the Clinical Maestro outsourcing platform, expanding functionality for [...]
Strategikon Pharma announces close of series a financing
SAN FRANCISCO, APRIL 22, 2021 /PRNewswire/ — Strategikon Pharma, a leader in digital business technology to accelerate planning, budgeting, and outsourcing for clinical trials, announced the closing of Series A financing. The [...]
Strategikon Pharma Announces New Software Release of Clinical Maestro
Latest Version Establishes Clinical Maestro as a Digital Business Transformation Leader for Clinical Trials SAN FRANCISCO, April 7, 2021 — Strategikon Pharma announced a global update for its Clinical Maestro™ platform [...]
MESSAGE FROM ANCA COPAESCU, CEO of Strategikon Pharma, developer of Clinical Maestro
The global coronavirus pandemic continues to impact us all in previously unimaginable ways, at both a personal and professional level. I am writing to update you on how we’re approaching [...]
Strategikon Pharma is now offering Clinical Maestro™, our clinical trial planning, budgeting and sourcing technology software pro bono to any company Sponsoring COVID-19 clinical trials, in order to help researchers battle this public health emergency faster.
The spread of COVID-19 continues to expand and the pharmaceutical industry is rising to the challenge of finding treatments and vigorously working together to develop potential vaccines to eliminate the [...]